Remdesivir and Flu Vaccinations not solutions to Covid Threat

WHO  Finds that  Gilead’s Remdesivir has ‘little or no effect’ on COVID-19 recovery or mortality

Nevertheless, Gilead expects to make $3.5 billion from Remdesivir this year

https://www.fiercepharma.com/pharma/gilead-s-remdesivir-has-little-or-no-effect-covid-19-recovery-or-mortality-who 

 

Study Finds Positive association between COVID-19 deaths and influenza vaccination rates in elderly people worldwide

https://peerj.com/articles/10112/ 

Share this page

Follow Us